Gut microbiota as a promising therapeutic target for age-related sarcopenia.
Ageing Res Rev
; 81: 101739, 2022 11.
Article
in En
| MEDLINE
| ID: mdl-36182084
ABSTRACT
Sarcopenia is characterized by a progressive loss of skeletal muscle mass and function with aging. Recently, sarcopenia has been shown to be closely related with gut microbiota. Strategies such as probiotics and fecal microbiota transplantation have shown potential to ameliorate the muscle loss. This review will focus on the age-related sarcopenia, in particular on the relationship between gut microbiota and age-related sarcopenia, how gut microbiota is engaged in sarcopenia, and the potential role of gut microbiota in the treatment of age-related sarcopenia.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sarcopenia
/
Gastrointestinal Microbiome
Limits:
Humans
Language:
En
Journal:
Ageing Res Rev
Journal subject:
GERIATRIA
Year:
2022
Document type:
Article
Affiliation country:
China